乔治全球健康研究院(澳大利亚)北京代表处

The George Institute for Global Health was established in 1999 with a mission to improve the health of millions of people worldwide, particularly underserved populations, by challenging the status quo and using innovative approaches to prevent and treat the world’s biggest killers: non-communicable diseases and injury. With offices in Australia, China, India and the UK, our 700+ people support 245+ active projects and clinical trials across 50+ countries, with 400+ more staff across our social enterprises. We focus on the global health challenges that cause the greatest loss of life, the greatest impairment of life quality and the most substantial economic burden, particularly in resource-poor settings. Our experts are among the most cited globally, bestowed accolades for excellence and innovation, and regularly participate in policy fora. Our research is published in leading academic journals, referenced in policy documents, and recognised for its excellence, innovation and impact. We are designated a WHO Collaborating Centre (WHO CC) for Injury Prevention & Trauma Care, and a WHO CC for Population Salt Reduction. Since 1999, we have raised more than $1 billion for research and produced over 10,000 peer-reviewed publications and other academic outputs. What we do (1) Lead world-class, large-scale clinical trials, epidemiological studies and health systems research to transform treatments and healthcare delivery;(2) Look beyond single diseases, across the life course, to identify patient-centred approaches to care that can be implemented at scale; (3)Develop low-cost, innovative solutions to global unmet needs; (4) Drive our global impact through a program of research, advocacy, thought leadership and disruptive social entrepreneurship.